Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and Nf-kB in human colon cancer

Life Sciences

Volumn 70, Issue 22, 2002, Pages 2631-2646

  Chen, George G ^a   Lee, Janet F Y ^a   Wang, Su H ^b   Chan, Ursula P F ^a   Ip, Ping C ^a   Lau, Wan Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Colon cancer; Peroxisome proliferator activated receptor gamma

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CIGLITAZONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL PROTECTION; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

APOPTOSIS; BIOLOGICAL RESPONSE MODIFIERS; CELL DIVISION; CELL SURVIVAL; COLON; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HT29 CELLS; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOENZYME TECHNIQUES; LIGANDS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN D2; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0037134255     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)01510-2     Document Type: Article

References (31)

1. Differentiation and reversal of malignant changes in colon cancer through PPARgamma
2. Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells
3. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells
4. Activators of the nuclear receptor PPARgamma enhance colon polyp formation
5. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice
6. A nuclear receptor to prevent colon cancer
7. Effects of ligand activation of peroxisome proliferator-activated receptor in human prostate cancer
8. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions
9. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma
10. Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions
11. The role of bcl-2 in the progression of the colorectal adenoma-carcinoma sequence
12. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins
13. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: Relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products
14. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells
15. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect
16. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
17. 15-Deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
18. Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis
19. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha
20. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis
21. c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression
22. Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions
23. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures
24. Loss-of-function mutations in PPAR gamma associated with human colon cancer
25. PPARgamma and colorectal carcinoma: Conflicts in a nuclear family
26. The transcription factor NF-kappaB: Control of oncogenesis and cancer therapy resistance
27. A pathway of neuronal apoptosis induced by hypoxia/reoxygenation: Roles of nuclear factor-kappaB and Bcl-2
28. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons
29. Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes
30. Bcl-Xshort is elevated following severe global ischemia in rat brains
31. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response